Demand For Prescription Delivery Services Market Is Expected To Ramp Up At Robust Pace During Foreca pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Safety of Oral DMTs for RRMS in Real-world Use Match Trial Findings multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ORLANDO, Fla., May 4, 2021 /PRNewswire/ Cabenuva (cabotegravir/rilpivrine), the first and only once-monthly complete injectable treatment is available through AllianceRx Walgreens Prime for adults living with human immunodeficiency virus type 1 (HIV-1). Manufactured for ViiV Healthcare by GlaxoSmithKline, Cabenuva provides an alternative to patients who relied on a daily oral treatment regimen.
HIV is a virus that attacks the body s immune system. If not treated, it can lead to acquired immunodeficiency syndrome (AIDS).
1 HIV-1 is the predominant type of HIV worldwide, making up 95 percent of all HIV cases worldwide.
2 Cabenuva a complete regimen for the treatment of HIV-1 infection in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.